or Try an Advanced Search...

    Technical Analysis for KNSA - Kiniksa Pharmaceuticals, Ltd.

    Grade Last Price % Change Price Change
    D 18.00 -3.59% -0.67
    KNSA closed down 3.59 percent on Monday, July 1, 2024, on 1.35 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
    Earnings due: Jul 23
    *** please verify all earnings dates ***
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical KNSA trend table...
    Date Alert Name Type % Chg
    Fell Below 200 DMA Bearish 0.00%
    Cup with Handle Other 0.00%
    Gapped Down Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    20 DMA Resistance Bearish -3.59%
    Pocket Pivot Bullish Swing Setup -3.59%
    Cup with Handle Other -3.59%
    Volume Surge Other -3.59%
    Cup with Handle Other -3.17%
    NR7 Range Contraction -3.17%
    Older End-of-Day Signals for KNSA ...

       Recent Intraday Alerts

    Alert Time
    Fell Below 10 DMA 3 days ago
    Possible NR7 3 days ago
    60 Minute Opening Range Breakdown 3 days ago
    Rose Above Previous Day's High 3 days ago
    20 DMA Resistance 3 days ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    KNSA Chart by TradingView
    Basic chart:

    Profile

    Kiniksa Pharmaceuticals Ltd is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Biopharmaceutical Disease Medication Pharmacology

    Is KNSA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 17 Kiniksa Pharmaceuticals Sponsors American Heart Association’s Addressing Recurrent Pericarditis Initiative
    Jun 4 Kiniksa Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
    May 7 Kiniksa Pharmaceuticals to Present at Bank of America Securities 2024 Health Care Conference
    Apr 24 Kiniksa Pharmaceuticals First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
    Apr 24 Kiniksa Pharmaceuticals: Arcalyst Performs While Abiprubart Plans Take Shape
    Apr 24 Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
    Apr 23 Kiniksa Pharmaceuticals, Ltd. (KNSA) Q1 2024 Earnings Call Transcript
    Apr 23 Kiniksa Pharmaceuticals, Ltd. 2024 Q1 - Results - Earnings Call Presentation
    Apr 23 Kiniksa Pharmaceuticals Ltd (KNSA) Q1 2024 Earnings Overview: Surpasses Revenue Forecasts
    Apr 23 Kiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates
    See more KNSA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 22.09
    52 Week Low 13.56
    Average Volume 391,531
    200-Day Moving Average 18.15
    50-Day Moving Average 18.98
    20-Day Moving Average 18.84
    10-Day Moving Average 18.50
    Average True Range 0.61
    RSI (14) 39.39
    ADX 14.35
    +DI 16.92
    -DI 29.92
    Chandelier Exit (Long, 3 ATRs) 18.01
    Chandelier Exit (Short, 3 ATRs) 19.21
    Upper Bollinger Bands 19.80
    Lower Bollinger Band 17.87
    Percent B (%b) 0.07
    BandWidth 10.22
    MACD Line -0.19
    MACD Signal Line -0.15
    MACD Histogram -0.0423
    Fundamentals Value
    Market Cap 637.37 Million
    Num Shares 35.4 Million
    EPS -0.11
    Price-to-Earnings (P/E) Ratio -163.64
    Price-to-Sales 5.38
    Price-to-Book 3.52
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 19.74
    Resistance 3 (R3) 19.73 19.13 19.45
    Resistance 2 (R2) 19.13 18.69 19.14 19.35
    Resistance 1 (R1) 18.57 18.42 18.27 18.58 19.26
    Pivot Point 17.97 17.97 17.83 17.98 17.97
    Support 1 (S1) 17.41 17.53 17.11 17.42 16.74
    Support 2 (S2) 16.81 17.26 16.82 16.65
    Support 3 (S3) 16.25 16.81 16.55
    Support 4 (S4) 16.26